Pershing Square Capital Management Lp Stocks Overview
Bill Ackman’s Pershing Square Capital Management Lp just filed its quarterly 13F. Dated 25/12/2015, the SEC filing reveals the hedge fund has a portfolio value of $13.95 billion, representing a decrease of $495.78 million from the previous quarter when it was $14.45 billion. Note: This filling reprents about 91.70% of Pershing Square Capital Management Lp’s assets, which which are listed in the US.
|Previous Mkt Value:||$14,445,833,000|
|Chg Mkt Value %:||-3.43 %|
|Turnover %:||0.00 %|
|Top 10 Holdings %:||100.01%|
Based on $15.21 billion in assets under management, Pershing Square Capital Management Lp’s equity exposure represents 91.70% of assets.
|Top 5 New Buys|
|Mondelez Intl Inc||13.02%|
|13F Sector Allocation|
|Health Care||37 %|
|Consumer Staples||13 %|
The hedge fund didn’t report any increased positions in this quarter.
Top 3 Positions
Valeant Pharmaceuticals Intl (VRX), Air Prods & Chems Inc (APD) and Canadian Pac Ry Ltd (CP) made up the majority of Pershing Square Capital Management Lp’s total US long portfolio in this quarter. These positions were top 3 and constitute 58.04% of Pershing Square Capital Management Lp’s US-listed securities.
The picture above provides a summary of Pershing Square Capital Management Lp’s top 10 US-listed positions in this quarter.
13F Sector Allocation
The fund decreased the Health Care, Materials and Finance sector positions by 37 %, 60 % and 63 %, respectively.
So these are Q3 2015 fund’s sector weights now: health care 37 % for $5.16 billion, materials 23 % for $3.21 billion, transports 14 % for $1.95 billion, consumer staples 13 % for $1.81 billion and finance 3 % for $418.50 million.
Important Position Changes
Top 10 Q3 2015 New Positions: Mondelez Intl Inc (MDLZ).
Fund New Positions
During this quarter, Bill Ackman’s Pershing Square Capital Management Lp started new position in Mondelez Intl Inc (MDLZ) for $1.82 billion. 1 is the only new position.
Pershing Square Capital Management Lp – website
13F Filing Link: 000117266115002091
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.